Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ophthalmology Market
5.1. COVID-19 Landscape: Ophthalmology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ophthalmology Market, By Product
8.1. Ophthalmology Market Revenue and Volume, by Product, 2023-2032
8.1.1. Device
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Drugs
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Ophthalmology Market, By Disease
9.1. Ophthalmology Market Revenue and Volume, by Disease, 2023-2032
9.1.1. Glaucoma
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Cataract
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Age-Related Macular Degeneration
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
9.1.4. Inflammatory Diseases
9.1.4.1. Market Revenue and Volume Forecast (2020-2032)
9.1.5. Refractive Disorders
9.1.5.1. Market Revenue and Volume Forecast (2020-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Ophthalmology Market, By Distribution Channel
10.1. Ophthalmology Market Revenue and Volume, by Distribution Channel, 2023-2032
10.1.1. Direct Tender
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Retail Sales
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Ophthalmology Market, By End User
11.1. Ophthalmology Market Revenue and Volume, by End User, 2023-2032
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Clinics
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Home Healthcare
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Ophthalmology Market, By End-User
12.1. Ophthalmology Market Revenue and Volume, by End-User, 2023-2032
12.1.1. Original Equipment Manufacturer
12.1.1.1. Market Revenue and Volume Forecast (2020-2032)
12.1.2. Aftermarket
12.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 13. Global Ophthalmology Market, By Actuators
13.1. Ophthalmology Market Revenue and Volume, by Actuators, 2023-2032
13.1.1. Hydraulic
13.1.1.1. Market Revenue and Volume Forecast (2020-2032)
13.1.2. Pneumatic
13.1.2.1. Market Revenue and Volume Forecast (2020-2032)
13.1.3. Electric
13.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 14. Global Ophthalmology Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.1.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.1.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.1.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.1.7. U.S.
14.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.1.7.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.1.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.1.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.1.8. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.1.8.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.1.9.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.1.9.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.1.9.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.1.10. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.1.11. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.2.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.2.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.2.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.2.8.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.2.8.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.2.9. Market Revenue and Volume Forecast, by End User (2020-2032)
14.2.10. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.2.10.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.2.11. Germany
14.2.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.2.11.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.2.11.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.2.12. Market Revenue and Volume Forecast, by End User (2020-2032)
14.2.13. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.2.14. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.2.15.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.2.15.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.2.15.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.2.16. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.2.16.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.2.17.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.2.17.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.2.17.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.2.18. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.2.18.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.3.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.3.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.3.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.3.7. India
14.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.3.7.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.3.8. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.3.9. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.3.10. China
14.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.3.10.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.3.10.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.3.10.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.3.11. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.3.11.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.3.12. Japan
14.3.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.3.12.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.3.12.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.3.12.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.3.12.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.3.12.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.3.13.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.3.13.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.3.13.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.3.13.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.3.13.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.4.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.4.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.4.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.4.7. GCC
14.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.4.7.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.4.8. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.4.9. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.4.10. North Africa
14.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.4.10.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.4.10.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.4.10.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.4.11. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.4.12. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.4.13. South Africa
14.4.13.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.4.13.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.4.13.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.4.13.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.4.13.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.4.13.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.4.14.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.4.14.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.4.14.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.4.14.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.4.14.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.5.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.5.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.5.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.5.7. Brazil
14.5.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.5.7.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.5.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.5.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.5.8. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.5.8.1. Market Revenue and Volume Forecast, by Actuators (2020-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
14.5.9.2. Market Revenue and Volume Forecast, by Disease (2020-2032)
14.5.9.3. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
14.5.9.4. Market Revenue and Volume Forecast, by End User (2020-2032)
14.5.9.5. Market Revenue and Volume Forecast, by End-User (2020-2032)
14.5.9.6. Market Revenue and Volume Forecast, by Actuators (2020-2032)
Chapter 15. Company Profiles
15.1. Alcon, Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Bausch Health Companies Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Carl Zeiss Meditec AG
15.3. BorgWarner Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Essilor International S.A.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Haag-Streit AG.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Johnson & Johnson Vision Care, Inc
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. NIDEK CO., LTD.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Novartis AG
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. STAAR Surgical Company
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Topcon Corporation
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
PROCEED TO BUY :
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client